ArticleFrontiers in oncology2023

Non-oncology drug (meticrane) shows anti-cancer ability in synergy with epigenetic inhibitors and appears to be involved passively in targeting cancer cells.

Yulu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.